Cerus Corp. (CERS)
2.655
-0.06
(-2.39%)
USD |
NASDAQ |
Aug 28, 16:00
2.655
0.00 (0.00%)
After-Hours: 19:46
Cerus Total Liabilities (Quarterly) : 134.47M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 134.47M |
| March 31, 2026 | 154.62M |
| December 31, 2025 | 156.89M |
| September 30, 2025 | 152.98M |
| June 30, 2025 | 156.90M |
| March 31, 2025 | 150.53M |
| December 31, 2024 | 144.02M |
| September 30, 2024 | 135.26M |
| June 30, 2024 | 135.20M |
| March 31, 2024 | 138.97M |
| December 31, 2023 | 144.30M |
| September 30, 2023 | 156.82M |
| June 30, 2023 | 147.17M |
| March 31, 2023 | 149.77M |
| December 31, 2022 | 149.53M |
| September 30, 2022 | 141.33M |
| June 30, 2022 | 139.70M |
| March 31, 2022 | 141.50M |
| December 31, 2021 | 151.88M |
| September 30, 2021 | 137.87M |
| June 30, 2021 | 138.99M |
| March 31, 2021 | 127.95M |
| December 31, 2020 | 117.61M |
| September 30, 2020 | 104.12M |
| June 30, 2020 | 100.97M |
| Date | Value |
|---|---|
| March 31, 2020 | 102.96M |
| December 31, 2019 | 108.48M |
| September 30, 2019 | 103.63M |
| June 30, 2019 | 109.00M |
| March 31, 2019 | 106.43M |
| December 31, 2018 | 78.94M |
| September 30, 2018 | 69.86M |
| June 30, 2018 | 61.40M |
| March 31, 2018 | 58.82M |
| December 31, 2017 | 59.30M |
| September 30, 2017 | 59.90M |
| June 30, 2017 | 44.19M |
| March 31, 2017 | 43.45M |
| December 31, 2016 | 45.69M |
| September 30, 2016 | 43.81M |
| June 30, 2016 | 45.81M |
| March 31, 2016 | 44.40M |
| December 31, 2015 | 44.64M |
| September 30, 2015 | 39.67M |
| June 30, 2015 | 40.88M |
| March 31, 2015 | 33.29M |
| December 31, 2014 | 40.26M |
| September 30, 2014 | 32.12M |
| June 30, 2014 | 32.64M |
| March 31, 2014 | 28.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DexCom, Inc. | 3.834B |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.19M |
| Shareholders Equity (Quarterly) | 70.02M |
| Debt to Equity Ratio | 1.097 |
| Current Ratio | 1.834 |
| Net Debt Paydown Yield | 0.77% |